3 / 18
Page 39
Virology research J 2017 Vol 1 Issue 2
Notes:
July 26-27, 2017 | Vancouver, Canada
WORLD CONFERENCE ON STDs, STIs & HIV/AIDS
allied
academies
Introduction:
One of the main routes of prevention from
the infectious diseases is vaccination. Due to the ageing
of the world population, the number of people who are at
risk of infections has increased. Moreover, because of the
common travels to the regions under risk and the increase in
the numbers of people who have chronic diseases, who got
immunosuppressive treatment, who got organ and/or tissue
transplantation and who are diagnosed with HIV/AIDS, adult
vaccination gained importance. In this study, it is aimed to
determine the main reasons of applying to adult vaccination
polyclinic and the response rates to HBV vaccination.
Material and Methods:
People who applied to adult
vaccination polyclinic in 10 years between 2006-2016
for HBV vaccination and who applied for pneumococcal
vaccination in last one year were evaluated in this study.
Socio-demographic features such as age, sex of the patients
were assessed, besides the indication for vaccination. HBV
vaccination was administered by 0.-1.-6 months schedule
for people who had no immunosuppressive disease or
condition. For people who are immunosuppressed, or solid
organ recipients or HIV/AIDS patients, the same scheme was
administered with double dose. Response to HBV vaccination
was assessed by the measure of anti HBs antibody and the
level of >10 IU/mL was considered as protective response.
Pneumococcal vaccine was administered with PCV13 and
PPSV-23 according to MMWR recommendations.
Results:
A total of 2808 patients who vaccinated for HBV in
ten years and 47 patients who vaccinated for pneumococcal
vaccines for one year were evaluated in the study. 58% and
21% of the vaccination applicants were female for HBV and
pneumococcal vaccination, respectively. The main indication
for HBV vaccination was living with a person who has HBV
infection (84%). Other vaccination indications were; to be
healthcare personnel (11.1%), to have chronic HCV infection
and other liver disease (5.5%), to be hemodialysis patient
(3.1%) and to have cancer (2.6%). The response for HBV
vaccination was evaluated in 2346 persons and 93.4% of
them was found in protective levels (>10 IU/mL).
Most of peoplewhohavebeenvaccinatedwithpneumococcal
vaccine were patients who are diagnosed with HIV/AIDS
(59.5%), followed by renal transplant candidates, who
performed splenectomy and who has recurrent meningitis.
Only three of the patients were 65 years or older.
Conclusion:
The HBV vaccination response rates were found
to be comparable with the general response of the vaccine.
It is observed that application number of people, who
applied for HBV vaccination and are under risk for sexually
transmitted diseases, is low. Moreover, the application rate
of people who applied for pneumococcal vaccination and
have chronic diseases such as diabetes mellitus, chronic
heart, kidney, liver, lung diseases and are over 65, was also
observed to below.
Evaluation of the admission reasons and the response rates of the HBV vaccination at the adult
vaccination polyclinic
Sukran Kose, Sabri Atalay, Melda Turken
and
Basak Gol Serin
Turkey